Literature DB >> 17075644

Ocular allergic disease: mechanisms, disease sub-types, treatment.

Mark B Abelson1, Lisa Smith, Matthew Chapin.   

Abstract

Ocular allergy refers to a variety of hypersensitivity disorders that affect the lid, conjunctiva, and/or cornea. Its incidence is estimated at over 20% of the general population in the United States. This review will discuss the various forms of ocular allergy, their pathophysiology, clinical presentation, and treatment. New frontiers in mechanisms, therapy, and management in the office are emphasized throughout.

Entities:  

Year:  2003        PMID: 17075644     DOI: 10.1016/s1542-0124(12)70140-4

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  14 in total

1.  The effect of allergic rhinitis with positive skin prick test on choroidal thickness.

Authors:  Alper Yenigun; Ahmet Elbay; Remzi Dogan; Orhan Ozturan; Mehmet Hakan Ozdemir
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-06       Impact factor: 2.503

Review 2.  Ocular diseases: immunological and molecular mechanisms.

Authors:  Jing Song; Yi-Fei Huang; Wen-Jing Zhang; Xiao-Fei Chen; Yu-Mian Guo
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

Review 3.  Antihistamines in ocular allergy: are they all created equal?

Authors:  Mark B Abelson; James T McLaughlin; Paul J Gomes
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

Review 4.  Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management.

Authors:  Stacey Ackerman; Lisa M Smith; Paulo J Gomes
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

Review 5.  [Influence of environmental factors on allergy development].

Authors:  W Schober; H Behrendt
Journal:  HNO       Date:  2008-08       Impact factor: 1.284

6.  Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis.

Authors:  Monica Baiula; Andrea Bedini; Gioia Carbonari; Samantha Deianira Dattoli; Santi Spampinato
Journal:  Front Pharmacol       Date:  2012-12-26       Impact factor: 5.810

7.  Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%.

Authors:  Jack V Greiner; Kimberly Edwards-Swanson; Avner Ingerman
Journal:  Clin Ophthalmol       Date:  2011-01-13

8.  Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis.

Authors:  Santa J Ono; Keith Lane
Journal:  Drug Des Devel Ther       Date:  2011-02-08       Impact factor: 4.162

9.  Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials.

Authors:  Joseph B Ciolino; Eugene B McLaurin; Nicholas P Marsico; Stacey L Ackerman; Julia M Williams; Linda Villanueva; David A Hollander
Journal:  Clin Ophthalmol       Date:  2015-05-02

Review 10.  Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis.

Authors:  DeGaulle I Chigbu; Alissa M Coyne
Journal:  Clin Ophthalmol       Date:  2015-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.